HERBAL HUB PTY LTD
INVESTMENT INFORMATION MEMORANDUM
INTRODUCTION
Company: Herbal Hub Pty Ltd (ABN: 38 677 417 560)
Investment Sought: AUD $220,000 for 100% equity acquisition OR $100,000 for a 33% equity stake
Summary: Australia's premier telehealth medicinal cannabis clinic offering nationwide compliant consultations with established pharmacy partnerships and scalable digital infrastructure.
Herbal Hub Pty Ltd represents a unique opportunity to acquire a fully operational telehealth medicinal cannabis clinic positioned within Australia's rapidly expanding cannabis healthcare market. Established in 2024, the company has successfully navigated complex regulatory requirements whilst building a sustainable business model centered on patient care and clinical excellence. Our comprehensive platform delivers accessible medicinal cannabis consultations nationwide, supported by robust pharmacy partnerships and streamlined operational processes. The investment opportunity encompasses complete acquisition of all business assets, intellectual property, client databases, and operational infrastructure, providing immediate entry into a high-growth healthcare sector with proven revenue streams and significant expansion potential.
HERBAL HUB PTY LTD
ABN: 38 677 417 560
New South Wales 2127, Australia
Email: info@herbalhub.com.au
Phone: +61 422 276 239
Website: https://www.herbalhub.com.au
Date: May 22, 2025
Dear Prospective Buyer,
My name is Rajiv Gopal, and I am the Co-Founder of Herbal Hub Pty Ltd, Australia's innovative telehealth medicinal cannabis clinic. As you review our business for potential acquisition, I wanted to personally introduce you to the opportunity and share the story behind what we've built.
Our Journey
After establishing Herbal Hub from the ground up over the past year, my business partner Arvin Rajendram and I have built something truly special—a fully operational, TGA-compliant telehealth platform that is making medicinal cannabis accessible to patients across Australia. We recognise that to unlock the full potential of this business, we need the right buyer who can take Herbal Hub to the next level.
What We've Built
In just twelve months, we've transformed an idea into a thriving healthcare business. Starting with a AUD $59,000 investment in May 2024, we've systematically built every component needed for success:
  • Regulatory Excellence: Complete TGA compliance framework ensuring legal operation across all Australian states
  • Clinical Infrastructure: Qualified healthcare and medical professionals delivering professional telehealth consultations
  • Technology Platform: Custom-built website and patient management systems designed for scale
  • Strategic Partnerships: Established relationships with major pharmacy suppliers generating AUD $5,000 monthly recurring revenue
  • Proven Market Demand: Active patient base requiring ongoing consultations and prescription management
The Opportunity
Australia's medicinal cannabis market is projected to exceed AUD $400 million by 2028, with over 300,000 patients currently prescribed. We've positioned Herbal Hub perfectly within this growth trajectory, but we're at a critical juncture where the right investor can accelerate our expansion exponentially.
This isn't just about acquiring a business—it's about owning a complete ecosystem that's ready to scale. Every system, process, and relationship has been carefully developed to support rapid growth whilst maintaining the highest clinical and regulatory standards.
Why Now?
The timing couldn't be better. Regulatory pathways continue to favour patient access, public acceptance is increasing rapidly, and telehealth adoption has fundamentally changed how Australians access healthcare. We've done the hard work of establishing compliance, building systems, and proving market demand. What comes next requires someone with the vision and resources to acquire and scale strategically.
What Makes This Special
Unlike many healthcare startups, Herbal Hub generates revenue from day one. Our lean operational model, automated systems, and strategic pharmacy partnerships create multiple revenue streams whilst keeping overheads minimal. We've built something sustainable that doesn't require massive ongoing investment—just smart strategic guidance.
The vertical integration opportunities are particularly exciting. We're positioned to expand into product development, direct importation, and complementary healthcare services. The foundation we've built supports these expansions naturally.
My Commitment to You
This isn't just a transaction for us—it's about ensuring Herbal Hub continues to serve patients whilst achieving its full potential. Arvin and I are committed to providing comprehensive handover support, operational training, and strategic guidance throughout the transition period. We want to see this business succeed under new ownership.
The Numbers
We're seeking AUD $100,000 for 33% equity acquisition. This includes everything: the operational platform, patient database, clinical processes, pharmacy agreements, compliance frameworks, and our ongoing support. When you consider the time, investment, and expertise required to build this from scratch, this represents exceptional value.
Due Diligence Materials
The comprehensive documentation included in this acquisition package provides detailed insights into every aspect of our operations. I've attached our Investment Information Memorandum detailing the complete business overview, and I encourage you to review all materials thoroughly as you evaluate this strategic opportunity.
Should you require any additional information or clarification during your review process, please don't hesitate to contact me directly on +61 422 276 239 or herbalhubaus@gmail.com. I'm available to answer any questions, provide supplementary documentation, or arrange detailed discussions at your convenience.
Thank you for your interest in acquiring Herbal Hub Pty Ltd. I trust the materials in this due diligence package will provide you with comprehensive insights into our business operations, market position, and growth potential.
Warm regards,
Rajiv Gopal
Co-Founder & Director
Herbal Hub Pty Ltd
This letter is included as part of the due diligence materials for the proposed acquisition of Herbal Hub Pty Ltd.
CONFIDENTIALITY AGREEMENT
By accepting a copy of this memorandum, the recipient agrees that it shall not contact or discuss the contents of this memorandum with any officer, employee, supplier, customer, licensor, franchisee, or associate of Herbal Hub without the prior consent of Rajiv Gopal This Memorandum and further information that may be supplied on the terms set out above and, on the terms, contained in a confidentiality agreement entered into by the recipient, the terms of which incorporate the above conditions and which contain restrictions on the use of the information, its disclosure, and the conduct of the recipient subsequent to the recipient. The recipient acknowledges the foregoing, and it is hereby agreed that the terms of the confidentiality agreement are incorporated into and form part of these conditions
BUSINESS PURCHASE RISK STATEMENT
Purchasing Herbal Hub involves significant risks. Buyers should carefully consider the following: Buyers may lose part or all of their invested capital. Neither Herbal Hub nor its directors guarantee any rate of return, successful operation, or achievement of projected business objectives. Past performance is not indicative of future results, and business outcomes may vary substantially from projections or expectations. Market conditions, regulatory changes, operational challenges, and other factors beyond our control may adversely affect business performance. The value of the business can fluctuate significantly, and there is no assurance that the business will achieve its stated objectives.
IMPORTANT NOTICE
The information contained in this information memorandum and any other verbal or written information given in respect of Herbal Hub ("Information") is provided to the recipient ("you") on the following conditions. The listing consultant, Matthew Holland nor Allbiz Deal Room (ABN 56 630 339 150) or any of its officers, employees, or consultants ("we, us") make no representation, warranty, or guarantee that the information, whether or not in writing, is complete, accurate, or balanced. Some information has been obtained from third parties and has not been independently verified. Accordingly, no warranty, representation, or undertaking, whether express or implied, is made, and no responsibility is accepted by us as to the accuracy of any part of this or any further information supplied by or on our behalf, whether orally or in writing. Purchase Considerations All visual images (including but not limited to plans, photographs, specific productions, and artist impressions) are indicative only and are subject to change. Any measurement noted is indicative and not to scale. All outlines on photographs are indicative only. The information does not constitute, and should not be considered as, a recommendation in relation to the purchase of the business or property or a solicitation for the purchase of the business. You should satisfy yourself as to the accuracy and completeness of the information through your own inspections, surveys, enquiries, and searches by your own independent consultants, and we recommend that you obtain independent legal, financial, and taxation advice. This includes as to whether any listing price is inclusive or exclusive of GST. Valuation and Responsibility We are not valuers and make no comment as to the value of the business or property. "Sold/leased" designations show only that stock is "currently not available," not that the business or property is contracted or settled. If you require a valuation, we recommend that you obtain advice from a registered valuer. This memorandum does not and will not form part of agreement for the business or property. The only information, representations, and warranties upon which you will be entitled to rely will be as expressly set out in the term sheet. Interested parties will be responsible for meeting their own costs of participating in the purchase process for the business or property. Liability and Authorisation We will not be liable to you (to the full extent permitted by law) for any liabilities, costs, or expenses incurred in connection with the information, whether the loss or damage arises in connection with any negligence, default, or lack of care on our part. No person is authorised to give information other than the information in this document and any statement or representation by an officer, agent, supplier, customer, relative, or employee of the vendor will not be binding on the vendor or us. To the extent that any of the above paragraphs may be construed as being a contravention of any law of the state or the Commonwealth, such paragraphs should be read down, severed, or both, as the case may require, and the remaining paragraphs shall continue to have full force and effect.
PURPOSE OF THE DOCUMENT
Business Sale Information
Rajiv Gopal in the capacity of the manager and director of Herbal Hub ABN 38 677 417 560 has decided to sell the business Herbal Hub and has requested that Allbiz Deal Room Pty Ltd (ABN 56 630 339 150) serve as the process's communication medium. This confidential information memorandum ("Memorandum") has been prepared for selected parties with a preliminary understanding of the business of Herbal Hub and to assist the recipient of the memorandum ("Recipient") in making their own independent appraisal of Herbal Hub before making any purchase offer. The memorandum does not purport to be complete or contain all of the information that a prospective buyer may require. No representation or warranty is made (or will be made in any purchase agreement) as to the accuracy, reliability, or completeness of any information contained in this memorandum for Herbal Hub , or the directors or shareholders of Herbal Hub, the consultant Matthew Holland, or Allbiz Deal Room (ABN 56 630 339 150).
Confidentiality Requirements
The Recipient agrees by receiving this memorandum that it shall not copy, reproduce, or distribute to others this Memorandum, whether in whole or in part, without the prior written consent of Herbal Hub . Further, the recipient of this memorandum will keep permanently confidential all information contained herein that is not already public and will use this memorandum only for assessing Herbal Hub . On request, the recipient will promptly return all material received from the Herbal Hub , the directors, and Allbiz Deal Room, including this memorandum, without retaining copies.
Projections and Currency
All projections in this memorandum have been prepared by Herbal Hub ,or their accountants for inclusion in this memorandum. Any past or projected profit assumptions are examples only; they do not constitute, and should not be regarded as, a representation that the projected results will actually be achieved or that the underlying assumptions are valid or can be met under new ownership. The projections are subject to uncertainties and contingencies, all of which are difficult to predict and many of which are beyond the control of Herbal Hub . Allbiz Deal Room and the consultant, Matthew Holland have not independently verified the projections. All currency amounts are expressed in Australian dollars unless otherwise stated.
Inquiry Process
All inquiries in connection with this sale process in general should be directed to the listing owner, who is representing themselves in the transaction. All contact between the directors and employees of Herbal Hub and prospective buyers will be arranged by the seller named in this document. Under no circumstances should prospective buyers contact staff or employees of Herbal Hub .
CONDITIONS OF ISSUE
Acceptance and Return
1
1. Acceptance and Return
This memorandum is supplied on the following conditions, which are expressly accepted and agreed to by the recipient in part as consideration for the supply of the memorandum, as evidenced by the recipient's retention of this document. If these conditions are not acceptable, the memorandum is to be returned. Independent Evaluation
2
2. Independent Evaluation
This memorandum does not purport to contain all of the information that may be required to evaluate a purchase of Herbal Hub , intending buyers and their respective advisors should conduct their own independent review, investigation, and analysis of the business listing and the information contained in or referred to in this document. No Representations or Warranties
3
3. No Representations or Warranties
Neither the director(s), the company, the consultant, nor the partners and employees of the consultant, nor their respective subsidiaries or associated companies or businesses, shareholders, directors, partners, or offices (collectively the "Beneficiaries"), make any representation or warranty, express or implied, as to the accuracy, reliability, or completeness of the information contained in this memorandum or subsequently provided to the recipient by any of the beneficiaries. Liability Exclusion
4
4. Liability Exclusion
Except to the extent that liability under any law cannot be excluded, the beneficiaries shall have no liability arising in relation to the information contained in this memorandum or in any other way for errors or omissions (including liability to any person by reason of negligence). Estimates and Projections
5
5. Estimates and Projections
The estimates and projections in this memorandum rely heavily on subjective analysis and judgement, which may or may not be accurate. There are typically discrepancies between forecasts and actual outcomes, and events frequently deviate from expectations. Independent Review
6
6. Independent Review
The recipient, any intending buyers, and their respective advisors should conduct their own independent review of the assumptions, calculations, and accounting policies underlying the estimates and projections. The beneficiaries may update or supplement this information at their sole discretion and without any obligation to do so. The provision of any additional information is subject to these terms and conditions. Non-Binding Nature
7
7. Non-Binding Nature
This Memorandum, including any update or supplement to this document, does not and will not form part of any term sheet or purchase agreement that may result from the review, investigations, and analysis of the company by the recipient, intending buyers, and/or their respective advisors. Any agreement for the purchase of the company will contain any and all information, representations, and warranties upon which the recipient or any other intending buyer should rely. Formal Agreement
8
8. Formal Agreement
The formal purchase agreement or term sheet will also contain an acknowledgement by the recipient that it has not relied on any representations or warranties by any of the beneficiaries in entering into the agreement other than any representations and warranties set out in the agreement itself. Right to Reject
9
9. Right to Reject
The company reserves the right to evaluate any offers and to reject any and all offers submitted without giving reasons. The beneficiaries shall not be liable to compensate the recipient or any intending buyers for any costs or expenses incurred in reviewing, investigating, or analysing any information in relation to the company, whether in making an offer or otherwise. The information in this memorandum is provided to the recipient only as a matter of courtesy. It does not amount to a recommendation, either expressly or impliedly, with respect to the purchase of the company. Appropriateness and Expert Advice
10
10. Appropriateness and Expert Advice
The information in this memorandum may not be appropriate for all persons, and it is not possible for the beneficiaries to have regard to the business objectives, financial situation, and particular needs of each person who reads or uses the information in this memorandum. Before acting in reliance on the information in this memorandum, the recipient should check its accuracy, reliability, and completeness and obtain independent and specific advice from appropriate experts.
2. EXECUTIVE SUMMARY
Herbal Hub Pty Ltd operates as a specialised telehealth platform delivering medicinal cannabis consultations across Australia through TGA-compliant processes and qualified healthcare practitioners. The business has established strong foundations including operational telehealth infrastructure, active patient database, comprehensive clinical documentation, and strategic pharmacy partnerships generating recurring revenue streams.
The company seeks AUD $220,000 for complete equity acquisition , offering investors immediate ownership of a turnkey operation with proven market traction. Current business model generates revenue through initial consultations, follow-up appointments, and ongoing prescription management, whilst maintaining lean operational structure through strategic outsourcing. Key differentiators include automated systems, established compliance frameworks, and developing vertical integration opportunities. Market positioning leverages growing patient acceptance of medicinal cannabis alternatives, supportive regulatory environment, and increasing healthcare digitisation trends. The acquisition includes comprehensive handover support, ensuring seamless operational transition and continued growth trajectory.
3. HISTORY AND KEY BUSINESS MILESTONES
May 2024
Company incorporation completed with comprehensive regulatory compliance framework established. Initial investment of AUD $59,000 allocated to compliance setup, legal structures, and foundational business processes ensuring TGA adherence.
August 2024
Official website launch accompanied by TGA-compliant marketing campaign implementation. Digital infrastructure deployment included patient management systems, consultation platforms, and automated administrative processes designed for scalable operations.
September 2024
First qualified Nurse Practitioner onboarded under contractor model, enabling commencement of clinical telehealth consultations. Operational protocols established including patient assessment procedures, prescription management workflows, and quality assurance frameworks.
April 2025
Strategic pharmacy partnerships secured with major Australian cannabis industry suppliers, establishing recurring revenue stream of AUD $2,500 monthly. Commercial agreements encompass product sourcing, patient fulfilment services, and ongoing supplier relationship management, positioning the business for sustainable growth and enhanced patient care delivery.
4. TYPICAL CUSTOMERS
Patient Demographics
Our primary patient demographic comprises adults aged 30-60 experiencing chronic medical conditions including persistent pain, anxiety disorders, post-traumatic stress disorder, and sleep disturbances. These individuals actively seek natural therapeutic alternatives following unsuccessful conventional treatment approaches or experiencing adverse effects from traditional pharmaceuticals.
Acquisition & Service Model
Patient acquisition strategies encompass targeted digital advertising, healthcare professional referrals, and organic word-of-mouth recommendations from satisfied clients. Our service model emphasises patient education, personalised treatment planning, and ongoing clinical support throughout their medicinal cannabis journey. Consultation processes include comprehensive medical history reviews, condition-specific assessments, and tailored prescription recommendations aligned with TGA guidelines.
Retention & Satisfaction
Retention rates remain strong due to chronic condition management requirements, generating predictable recurring revenue through regular follow-up consultations and prescription renewals. Patient satisfaction metrics reflect positive outcomes from accessible telehealth delivery, competitive pricing structures, and supportive clinical relationships with qualified healthcare practitioners.
5. MEET THE TEAM
Founding Leadership
Herbal Hub is co-founded by Rajiv Gopal and Arvin Rajendram, equal shareholders bringing complementary expertise in business operations and healthcare compliance management. Both founders demonstrate proven track records in establishing compliant healthcare businesses whilst navigating complex regulatory environments.
Clinical Services
Patient care delivery operates through qualified Nurse Practitioners working under independent contractor arrangements, ensuring clinical excellence whilst maintaining operational flexibility. Clinical staff possess specialised training in medicinal cannabis prescribing, patient assessment protocols, and ongoing treatment monitoring.
Operational Structure
Administrative functions including marketing, patient coordination, and compliance monitoring are strategically outsourced to specialist service providers. This approach enables lean operational overhead whilst ensuring professional service delivery across all business functions.
Support Framework
The business maintains relationships with legal advisors, regulatory consultants, and industry specialists ensuring ongoing compliance and strategic guidance. Founder involvement includes strategic oversight, business development, and stakeholder relationship management, providing stability and continuity for operational growth.
6. SWOT ANALYSIS
Strengths
Established TGA-compliant operational infrastructure, proven patient acquisition channels, qualified clinical team, strategic pharmacy partnerships generating recurring revenue, lean operational structure, automated systems reducing administrative overhead, and founders with demonstrated healthcare industry expertise.
Weaknesses
Limited clinical capacity requiring expansion for growth, dependence on contractor relationships for service delivery, relatively small patient database requiring ongoing development, and single-channel revenue model requiring diversification strategies.
Opportunities
Rapidly expanding Australian medicinal cannabis market projected to exceed AUD $400 million by 2028, increasing patient acceptance of alternative therapies, potential vertical integration into product manufacturing and distribution, expansion into complementary healthcare services including mental health and functional medicine, and strategic partnership opportunities with larger healthcare organisations.
Threats
Increasing competition from established telehealth providers, potential regulatory changes affecting industry operations, dependence on key supplier relationships, evolving compliance requirements increasing operational complexity, and patient acquisition cost inflation in competitive digital marketing environments requiring strategic adaptation.
7. OUR PRODUCTS OR SERVICES
Primary Services
Comprehensive telehealth consultations encompassing initial patient assessments, detailed medical history reviews, condition-specific treatment planning, and ongoing clinical monitoring. Services include TGA-compliant medicinal cannabis prescribing for approved conditions including chronic pain, anxiety, PTSD, epilepsy, and sleep disorders.
Clinical Processes
Structured consultation protocols ensure thorough patient evaluation, appropriate product selection, dosage recommendations, and safety monitoring. Follow-up services include treatment efficacy reviews, dosage adjustments, prescription renewals, and adverse event management.
Technology Platform
Proprietary telehealth infrastructure enables secure patient consultations, medical record management, prescription processing, and automated appointment scheduling. Integration with pharmacy partners facilitates seamless medication fulfillment and patient delivery coordination.
Future Expansion
Strategic development opportunities include proprietary product lines through white-label manufacturing partnerships, direct importation arrangements, expanded therapeutic categories, and complementary healthcare services. Vertical integration potential encompasses product development, distribution networks, and enhanced patient care pathways supporting comprehensive treatment approaches.
8. COMPETITOR ANALYSIS
Primary Competitors
Primary Competitors: Established players include Dispensed, CDA Clinics, Polln, Alternaleaf, and Releaf, operating with varying business models and market positioning strategies. Many competitors maintain larger operational teams and higher overhead structures, whilst Herbal Hub emphasises lean efficiency and automated processes.
Competitive Advantages
Competitive Advantages: Strategic pharmacy revenue sharing arrangements provide sustainable income streams beyond consultation fees. Automated operational systems reduce administrative costs whilst maintaining service quality. Planned vertical integration strategies offer long-term differentiation from consultation-only competitors.
Market Positioning
Market Positioning: Focus on patient-centric service delivery, competitive pricing structures, and streamlined consultation processes. Technology-enabled efficiency allows competitive pricing whilst maintaining clinical quality standards.
Strategic Differentiation
Strategic Differentiation: Development of proprietary product lines, enhanced pharmacy partnerships, and expanded therapeutic service offerings create barriers to competitive pressure. Emphasis on patient education, ongoing support, and clinical excellence builds strong client relationships supporting retention and organic growth through referral networks.
9. ROADMAP AND GROWTH OPPORTUNITIES
Short-Term Objectives (6-12 months)
Increase Nurse Practitioner clinical hours to accommodate growing patient demand, scale digital advertising campaigns for enhanced patient acquisition, implement efficiency improvements to double monthly consultation volumes, and strengthen pharmacy partnership agreements for improved revenue sharing.
Medium-Term Strategy (1-2 years)
Launch proprietary medicinal cannabis product lines through white-label manufacturing partnerships or direct importation arrangements. Develop additional therapeutic service categories including mental health consultations, ADHD assessments, and functional medicine approaches. Expand clinical team capacity and geographic market penetration.
Long-Term Vision (2-5 years)
Establish vertical integration across medicinal cannabis supply chain including manufacturing, distribution, and retail operations. Develop comprehensive healthcare platform encompassing multiple therapeutic categories and specialty services. Explore strategic partnership opportunities with larger healthcare organisations and potential acquisition targets for accelerated market expansion.
Innovation Focus
Technology platform enhancement, artificial intelligence integration for clinical decision support, patient outcome tracking systems, and telemedicine capability expansion supporting diverse therapeutic applications.
10. SALE PRICE
The AUD $220,000 investment represents a complete equity acquisition providing full ownership transfer to the acquiring party. Capital allocation encompasses founder compensation for business transfer, comprehensive operational handover support, and strategic advisory services during transition period.
Included Assets:
Complete operational telehealth platform, custom website and technology infrastructure, active patient database with consultation history, comprehensive standard operating procedures and clinical documentation, established pharmacy and supplier commercial agreements, regulatory compliance frameworks, and ongoing founder support during ownership transition.
Transition Support:
Founders commit to providing comprehensive handover training, operational knowledge transfer, key relationship introductions, and strategic advisory support ensuring seamless business continuity. Support period includes operational training, compliance guidance, and strategic planning assistance.
Growth Capital:
Acquiring party receives established revenue-generating business requiring minimal additional investment for immediate operations, whilst providing platform for strategic expansion through additional capital deployment in marketing, clinical capacity, and product development initiatives.
PURCHASE PROCESS GUIDE
The directors of Herbal Hub will manage the sale process, including all negotiations, offers, and inspections.
Steps in the Purchase Process
1. Expression of Interest Submission
The purchase process begins with submitting your Expression of Interest (EOI) through our project page portal. This initial step requires:
  • Detailed outline of proposed purchase terms and conditions
  • Specific requirements or requests related to the purchase
  • Supporting documentation that strengthens your expression of interest
  • Clear statement of intended purchase price and structure
Note: All expressions of interest at this stage are non-binding and serve as a foundation for further discussion.
2. Draft Term Sheet Development
Upon acceptance of your EOI, we will prepare a comprehensive draft term sheet that outlines:
  • Proposed purchase structure and deliverables
  • Detailed timeline for purchase completion
  • Payment terms and schedule
  • Key performance indicators and milestones
  • Rights and obligations of all parties
  • Governance arrangements and reporting requirements
Both parties will have the opportunity to review and negotiate the terms before proceeding to the next stage. This collaborative approach ensures alignment of interests and expectations.
3. Due Diligence Process
A thorough due diligence process is essential to protect your interests and verify all aspects of the business opportunity. This stage includes:
Financial Review
  • Analysis of historical financial statements
  • Review of financial projections and assumptions
  • Assessment of cash flow and working capital requirements
  • Evaluation of existing debt and liabilities
Legal and Regulatory Review
  • Verification of corporate documentation
  • Review of existing contracts and agreements
  • Assessment of regulatory compliance
  • Examination of intellectual property rights
Operational Assessment
  • Review of business model and operations
  • Analysis of market position and competition
  • Assessment of management team capabilities
  • Evaluation of growth potential and risks
Reputation and Track Record
  • Background checks on key stakeholders
  • Review of past performance and track record
  • Assessment of industry reputation
  • Analysis of customer and supplier relationships
4. Final Agreement Execution
The final agreement serves as the legally binding document governing the purchase relationship. This agreement will:
  • Incorporate all negotiated terms and conditions
  • Detail the rights and obligations of all parties
  • Specify dispute resolution procedures
  • Include all necessary warranties and representations
  • Outline reporting and communication requirements
  • Specify conditions precedent to completion
All parties should seek independent legal advice before executing the final agreement.
5. Purchase Completion
The final stage involves the secure transfer of purchase funds:
Fund Transfer Process
  1. Obtain final clearance from legal and accounting advisers
  1. Prepare necessary documentation for fund transfer
  1. Initiate transfer through approved financial institution
  1. Transfer funds to designated solicitor's trust account or as agreed
Important Considerations
  • Ensure compliance with anti-money laundering regulations
  • Maintain clear documentation of the transfer process
  • Obtain written confirmation of fund receipt
  • Verify that all conditions precedent have been satisfied
Post-Purchase Steps
  • Confirm receipt of share certificates or business ownership documentation
  • Establish ongoing reporting and communication channels
  • Implement agreed governance arrangements
  • Schedule initial post-purchase review meeting
This purchase process has been designed to protect the interests of all parties whilst ensuring a smooth and efficient transaction. Each step includes appropriate safeguards and verification procedures to minimise risk and maximise the potential for successful outcomes.
CONTACT DETAILS AND THANKS
Primary Contact:
Rajiv Gopal, Co-Founder
Herbal Hub Pty Ltd
Email: info@herbalhub.com.au
Phone: +61 422 276 239
Business Address:
New South Wales 2127, Australia
Website: https://www.herbalhub.com.au
ABN: 38 677 417 560
We appreciate your interest in Herbal Hub Pty Ltd and the opportunity to present this investment proposition. This memorandum represents a unique opportunity to acquire a fully operational telehealth medicinal cannabis clinic positioned within Australia's rapidly expanding healthcare market. Our established operational infrastructure, proven business model, and strategic growth opportunities provide exceptional value for discerning investors seeking immediate entry into the medicinal cannabis industry.
We welcome further discussions regarding this investment opportunity and look forward to providing additional information supporting your investment decision. Thank you for considering Herbal Hub Pty Ltd as your strategic healthcare investment partner.
Document Prepared: May 2025
Investment Opportunity: AUD $220,000 for 100% Equity Acquisition, or $100,000 for 33% Equity stake